Centene (CNC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks
02-04

For the quarter ended December 2024, Centene (CNC) reported revenue of $40.81 billion, up 3.4% over the same period last year. EPS came in at $0.80, compared to $0.45 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $38.96 billion, representing a surprise of +4.75%. The company delivered an EPS surprise of +63.27%, with the consensus EPS estimate being $0.49.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Centene performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Total Medical Health (Benefits) loss Ratios -Total Ratio (HBR): 89.6% compared to the 90% average estimate based on five analysts.
  • Membership Medicaid - Traditional Medicaid: 11.41 million versus 11.38 million estimated by three analysts on average.
  • Membership by line of business - Medicaid: 13 million versus the three-analyst average estimate of 12.98 million.
  • Membership Medicaid - High Acuity Medicaid: 1.6 million versus 1.6 million estimated by three analysts on average.
  • Revenues- Premium and service revenues: $36.30 billion versus the five-analyst average estimate of $35.50 billion. The reported number represents a year-over-year change of +2.7%.
  • Revenues- Premium: $35.52 billion versus $34.71 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +3.8% change.
  • Revenues- Service: $777 million versus the five-analyst average estimate of $782.17 million. The reported number represents a year-over-year change of -29.8%.
  • Revenues- Premium tax: $4.51 billion versus the five-analyst average estimate of $3.07 billion. The reported number represents a year-over-year change of +9.4%.
  • Revenues- Premium and service revenues- Commercial: $8.72 billion versus $8.47 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +17.8% change.
  • Revenues- Premium and service revenues- Medicare: $5.48 billion compared to the $5.70 billion average estimate based on three analysts. The reported number represents a change of +3.5% year over year.
  • Revenues- Premium and service revenues- Medicaid: $20.83 billion versus the three-analyst average estimate of $20.16 billion. The reported number represents a year-over-year change of -1.4%.
  • Revenues- Premium and service revenues- Other: $1.27 billion versus $1.19 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -16.8% change.
View all Key Company Metrics for Centene here>>>

Shares of Centene have returned +3.4% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Centene Corporation (CNC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10